These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36378004)

  • 1. Effect of Rapid Centrifugation Using High Centrifugal Force on Procoagulant Activity in Plasma Samples.
    Matsuda M; Komiyama Y; Suzuki T; Moriyama M
    Clin Lab; 2022 Nov; 68(11):. PubMed ID: 36378004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid preparation of plasma for coagulation testing.
    Pappas AA; Palmer SK; Meece D; Fink LM
    Arch Pathol Lab Med; 1991 Aug; 115(8):816-7. PubMed ID: 1863193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of time and temperature variables on routine coagulation tests.
    Adcock D; Kressin D; Marlar RA
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):463-70. PubMed ID: 9818995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Rapid Centrifugation Technique with Conventional Centrifugation for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) Testing.
    Chandler E; Kakkar N; Kaur R
    Indian J Hematol Blood Transfus; 2019 Jan; 35(1):161-166. PubMed ID: 30828165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-minute preparation of platelet-poor plasma for routine coagulation testing.
    Sultan A
    East Mediterr Health J; 2010 Feb; 16(2):233-6. PubMed ID: 20799581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
    Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
    Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.
    van den Besselaar AM; Meeuwisse-Braun J; Jansen-Grüter R; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):226-31. PubMed ID: 3603414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rapid centrifugation for routine coagulation testing].
    Boudaoud L; Divaret G; Marie P; Bezeaud A
    Ann Biol Clin (Paris); 2006; 64(4):315-7. PubMed ID: 16829473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automation of routine coagulation testing using a random access centrifugal analyzer.
    Rowell JA; Elms MJ; Young J; Bunce IH
    Am J Clin Pathol; 1988 Mar; 89(3):347-52. PubMed ID: 3348169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Pre-analytical Conditions on Prothrombin Time and Partial Activated Thromboplastin Time.
    Beatriz M; Beatriz P; Rita C; Helena A; Monica B
    Curr Pharm Biotechnol; 2019; 20(4):327-331. PubMed ID: 30868948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A; Barbaste C; Gabaig AM; Trumel C; Abella-Bourges N; Guelfi JF; Bousquet Mélou A
    Vet Clin Pathol; 2005 Sep; 34(3):237-42. PubMed ID: 16134071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions.
    Rao LV; Okorodudu AO; Petersen JR; Elghetany MT
    Clin Chim Acta; 2000 Oct; 300(1-2):13-21. PubMed ID: 10958859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?
    Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
    J Thromb Thrombolysis; 2019 Aug; 48(2):277-283. PubMed ID: 31098816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle.
    Gaudard M; Boissier E; Talon L; Douxfils J; Sapin AF; Sinegre T; Lebreton A
    Int J Lab Hematol; 2022 Jun; 44(3):610-618. PubMed ID: 35029031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy screening in children with heparinized central venous catheters.
    Ellis MR
    Pediatrics; 1993 Jun; 91(6):1147-50. PubMed ID: 8502518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-associated coagulation inhibitor (LACI) is a cofactor for heparin: synergistic anticoagulant action between LACI and sulfated polysaccharides.
    Wun TC
    Blood; 1992 Jan; 79(2):430-8. PubMed ID: 1346095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.
    Adcock DM; Kressin DC; Marlar RA
    Am J Clin Pathol; 1997 Jan; 107(1):105-10. PubMed ID: 8980376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.